HopeStage
Back to all studies
Not Yet RecruitingNCT07342465

Gamma Light and Sound Stimulation in Schizophrenia

Device studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
CambridgeSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: December 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
20
Sponsor
Massachusetts Institute of Technology
Sponsor type
Research institute
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT07342465
Official title
Show the full official title

Safety, Feasibility, and Preliminary Efficacy of Non-invasive Gamma Neuromodulation in Individuals With Schizophrenia Spectrum Disorders

Recruitment & locations

Not yet recruiting

Cambridge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts Institute of Technology, a research institute.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies